Curis Inc

Ownership Transactions Reported by 11 Insiders

Symbol
CRIS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
128 Spring Street, Building C, Suite 500, Lexington, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/6/2023

Curis Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James E. Dentzer President & CEO, Director $1.16 M May 21, 2024
Lori Anne Kunkel Director $988 K Jan 31, 2022
Jonathan B. Zung Cdo $473 K May 21, 2024
Diantha Duvall Cfo $453 K May 21, 2024
William Steinkrauss Chief Financial Officer $299 K Jan 29, 2022
Robert Martell Head of Research & Development $291 K Jan 20, 2023
Kenneth I. Kaitin Director $49.4 K May 21, 2024
Martyn D. Greenacre Director $49.4 K May 21, 2024
John Hohneker Director $49.4 K May 21, 2024
Marc Rubin Director $49.4 K May 21, 2024
Anne Borgman Director $49.4 K May 21, 2024

Recent Insider Transactions by Companies or Individuals for Curis Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership